Search Results

GSK2830371 50mg  | Purity Not Available

Selleck Chemicals

GSK2830371 is an orally active, allosteric Wip1 phosphatase inhibitor with IC50 of 6 nM.

More Information Supplier Page

GSK2830371 200mg  | Purity Not Available

Selleck Chemicals

GSK2830371 is an orally active, allosteric Wip1 phosphatase inhibitor with IC50 of 6 nM.

More Information Supplier Page

AGK2 100mg  | Purity Not Available

Selleck Chemicals

AGK2 is a potent, and selective SIRT2 inhibitor with IC50 of 3.5 μM that minimally affects either SIRT1 or SIRT3 at 10-fold higher levels.

More Information Supplier Page

AGK2 25mg  | Purity Not Available

Selleck Chemicals

AGK2 is a potent, and selective SIRT2 inhibitor with IC50 of 3.5 μM that minimally affects either SIRT1 or SIRT3 at 10-fold higher levels.

More Information Supplier Page

GSK-LSD1 2HCl 100mg  | Purity Not Available

Selleck Chemicals

GSK-LSD1 2HCl is an irreversible, and selective LSD1 inhibitor with IC50 of 16 nM, > 1000 fold selective over other closely related FAD utilizing enzymes (i.e. LSD2, MAO-A, MAO-B).

More Information Supplier Page

GSK-LSD1 2HCl 25mg  | Purity Not Available

Selleck Chemicals

GSK-LSD1 2HCl is an irreversible, and selective LSD1 inhibitor with IC50 of 16 nM, > 1000 fold selective over other closely related FAD utilizing enzymes (i.e. LSD2, MAO-A, MAO-B).

More Information Supplier Page

GSK-LSD1 2HCl 5mg  | Purity Not Available

Selleck Chemicals

GSK-LSD1 2HCl is an irreversible, and selective LSD1 inhibitor with IC50 of 16 nM, > 1000 fold selective over other closely related FAD utilizing enzymes (i.e. LSD2, MAO-A, MAO-B).

More Information Supplier Page

XL413 5mg  | Purity Not Available

Selleck Chemicals

XL413 is a potent and selective cell division cycle 7 homolog (CDC7) kinase inhibitor with IC50 of 3.4 nM, showing 63-, 12- and 35-fold selectivity over CK2, Pim-1 and pMCM2, respectively.

More Information Supplier Page

XL413 25mg  | Purity Not Available

Selleck Chemicals

XL413 is a potent and selective cell division cycle 7 homolog (CDC7) kinase inhibitor with IC50 of 3.4 nM, showing 63-, 12- and 35-fold selectivity over CK2, Pim-1 and pMCM2, respectively.

More Information Supplier Page